MetLife, Inc. $MET Shares Sold by KMG Fiduciary Partners LLC

KMG Fiduciary Partners LLC decreased its stake in MetLife, Inc. (NYSE:MET) by 91.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,192 shares of the financial services provider’s stock after selling 57,138 shares during the period. KMG Fiduciary Partners LLC’s holdings in MetLife were worth $439,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. lifted its position in MetLife by 12.1% during the 4th quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock worth $5,727,518,000 after acquiring an additional 7,805,814 shares in the last quarter. Pzena Investment Management LLC grew its position in MetLife by 22.9% in the fourth quarter. Pzena Investment Management LLC now owns 11,883,338 shares of the financial services provider’s stock valued at $938,071,000 after acquiring an additional 2,211,315 shares in the last quarter. Norges Bank acquired a new stake in MetLife in the fourth quarter valued at approximately $639,986,000. Invesco Ltd. raised its stake in shares of MetLife by 2.6% during the fourth quarter. Invesco Ltd. now owns 7,012,198 shares of the financial services provider’s stock valued at $553,543,000 after purchasing an additional 176,811 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of MetLife by 2.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,201,175 shares of the financial services provider’s stock worth $410,581,000 after purchasing an additional 126,098 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on MET shares. Wall Street Zen downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Piper Sandler lifted their price target on shares of MetLife from $86.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 24th. TD Cowen boosted their price objective on shares of MetLife from $87.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 22nd. Keefe, Bruyette & Woods upped their price objective on shares of MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a research report on Tuesday. Finally, UBS Group raised their target price on MetLife from $102.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and an average price target of $101.07.

Key Headlines Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: JPMorgan raised its price target for MetLife from $106 to $108 and maintained an “overweight” rating. The new target implies approximately 11.6% upside from the referenced $96.78 level, signaling continued confidence in the insurer’s earnings and valuation. Benzinga report
• Positive Sentiment: Keefe, Bruyette & Woods also increased its price target from $105 to $108 and reaffirmed an “outperform” rating. The second target increase reinforces the constructive analyst view of MetLife’s prospects. Benzinga report Ticker Report article
• Neutral Sentiment: MetLife Pet Insurance announced a partnership with America’s VetDogs to help co-raise a future service dog for a veteran or first responder with disabilities. The initiative may enhance brand reputation and community engagement, but is unlikely to materially affect near-term financial results. MetLife Pet Insurance and America’s VetDogs partnership
• Neutral Sentiment: MetLife highlighted benefits and employee well-being in its 2025 Sustainability Report. The disclosure may support long-term stakeholder and corporate-responsibility goals, though it is not an immediate earnings catalyst. MetLife 2025 Sustainability Report

MetLife Stock Performance

MetLife stock opened at $96.78 on Wednesday. MetLife, Inc. has a 52 week low of $67.33 and a 52 week high of $100.93. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52. The stock has a market cap of $62.27 billion, a P/E ratio of 18.54, a price-to-earnings-growth ratio of 0.75 and a beta of 0.78. The stock has a 50 day moving average of $90.68 and a 200-day moving average of $81.14.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.30 by $0.13. The business had revenue of $13.52 billion during the quarter, compared to analyst estimates of $19.67 billion. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The business’s revenue was up 10.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.02 earnings per share. On average, analysts expect that MetLife, Inc. will post 9.75 EPS for the current fiscal year.

MetLife Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be given a $0.5925 dividend. The ex-dividend date of this dividend is Tuesday, August 4th. This represents a $2.37 annualized dividend and a dividend yield of 2.4%. MetLife’s payout ratio is presently 45.40%.

MetLife declared that its board has approved a share buyback program on Wednesday, August 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.